Published in BMJ on November 22, 2013
Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease. Heart (2015) 1.49
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial. J Am Heart Assoc (2015) 1.46
Replacing β agonists with antimuscarinic drugs in patients with COPD. BMJ (2014) 0.99
Major changes in practice and interpreting data from the past. BMJ (2014) 0.95
Total joint arthroplasty and the risk of myocardial infarction: a general population, propensity score-matched cohort study. Arthritis Rheumatol (2015) 0.92
β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study. J Am Heart Assoc (2015) 0.86
Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.83
The double jeopardy of chronic obstructive pulmonary disease and myocardial infarction. Open Heart (2014) 0.83
Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.80
Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease. Heart (2016) 0.78
β2-Adrenoceptor involved in smoking-induced airway mucus hypersecretion through β-arrestin-dependent signaling. PLoS One (2014) 0.78
Systems Medicine 2.0: potential benefits of combining electronic health care records with systems science models. J Med Internet Res (2015) 0.77
Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study. BMJ Open (2016) 0.77
Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people. Eur J Heart Fail (2016) 0.76
Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study. Eur J Clin Pharmacol (2016) 0.76
β blockers for adults with chronic obstructive pulmonary disease. BMJ (2013) 0.75
Author's reply to Wolstenholme and Sanfilippo and colleagues. BMJ (2014) 0.75
Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant? ERJ Open Res (2015) 0.75
Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011. BMJ Open (2017) 0.75
Acute exacerbation of COPD: is it the "stroke of the lungs"? Int J Chron Obstruct Pulmon Dis (2016) 0.75
Topical Beta-Blockers and Cardiovascular Mortality: Systematic Review and Meta-Analysis with Data from the EPIC-Norfolk Cohort Study. Ophthalmic Epidemiol (2016) 0.75
Effect of β-blockade on lung function, exercise performance and dynamic hyperinflation in people with arterial vascular disease with and without COPD. BMJ Open Respir Res (2017) 0.75
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med (2007) 19.86
Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax (2002) 8.77
A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31
Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med (1998) 6.14
Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med (2002) 4.27
Mortality in COPD: Role of comorbidities. Eur Respir J (2006) 4.14
Risk indexes for exacerbations and hospitalizations due to COPD. Chest (2007) 3.55
Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD. Thorax (2007) 3.39
Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2005) 3.08
Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med (2003) 2.90
Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ (2011) 2.88
Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch Intern Med (2010) 2.82
The Myocardial Ischaemia National Audit Project (MINAP). Heart (2010) 2.80
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax (2010) 2.26
Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest (2009) 2.16
Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol (2007) 1.52
Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol (2010) 1.41
Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol (2001) 1.26
Chronic obstructive pulmonary disease after myocardial infarction in the community. Am Heart J (2010) 1.19
The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest (2011) 1.16
Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. Eur J Heart Fail (2004) 1.09
Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes. Am J Cardiol (2008) 1.09
Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions. Int J Chron Obstruct Pulmon Dis (2007) 1.04
Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction. Am J Cardiol (2010) 0.98
Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary disease. Can Respir J (2006) 0.93
Can beta-blockers be used for people with COPD? Drug Ther Bull (2011) 0.90
Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet (1997) 10.44
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 10.05
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax (2002) 8.77
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax (1999) 8.63
Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study. BMJ (1997) 6.13
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 5.49
Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet (1993) 5.43
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 5.17
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax (2000) 4.45
Why inequalities in health matter to primary care. Br J Gen Pract (2001) 4.39
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax (2002) 4.26
Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation (2002) 3.63
COPD exacerbations: definitions and classifications. Eur Respir J Suppl (2003) 3.35
Psychosocial work characteristics and social support as predictors of SF-36 health functioning: the Whitehall II study. Psychosom Med (1998) 3.05
Acute myocardial infarction in women: contribution of treatment variables to adverse outcome. Am Heart J (2000) 2.97
COPD exacerbations .1: Epidemiology. Thorax (2006) 2.94
Relative contribution of early life and adult socioeconomic factors to adult morbidity in the Whitehall II study. J Epidemiol Community Health (2001) 2.69
Socio-economic status and blood pressure: an overview analysis. J Hum Hypertens (1998) 2.68
Effects of ambient temperature on the incidence of myocardial infarction. Heart (2009) 2.62
Arterialised earlobe blood gas analysis: an underused technique. Thorax (1994) 2.48
How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet (1999) 2.38
Effects of air pollution on the incidence of myocardial infarction. Heart (2009) 2.33
Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study. BMJ (2008) 2.32
How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis Rheum (2008) 2.27
Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet (1999) 2.27
Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2004) 2.24
Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am J Respir Crit Care Med (1995) 2.20
Measles, mumps, and rubella (MMR) vaccine and autism. Ecological studies cannot answer main question. BMJ (2001) 2.15
Respiratory medicine: fighting for survival. BMJ (1992) 2.15
Health transition in Africa: practical policy proposals for primary care. Bull World Health Organ (2010) 2.10
Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax (2000) 2.06
Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol (2002) 2.03
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J (2007) 2.03
Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J (2000) 2.00
Is retirement good or bad for mental and physical health functioning? Whitehall II longitudinal study of civil servants. J Epidemiol Community Health (2003) 1.98
How effective are rapid access chest pain clinics? Prognosis of incident angina and non-cardiac chest pain in 8762 consecutive patients. Heart (2006) 1.98
Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J (2006) 1.94
Rapid assessment of chest pain. BMJ (2001) 1.82
Relationship between depression and exacerbations in COPD. Eur Respir J (2008) 1.81
Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ (2007) 1.81
Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J (2003) 1.78
Human gene for physical performance. Nature (1998) 1.78
Tackling health inequalities in primary care. BMJ (1999) 1.74
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network. Thorax (2005) 1.71
Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax (1996) 1.69
Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study. Thorax (2008) 1.68
Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J (2005) 1.67
Are there age and sex differences in the investigation and treatment of heart failure? A population-based study. Br J Gen Pract (2000) 1.67
Portable oxygen therapy: assessment and usage. Respir Med (1991) 1.66
Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax (1998) 1.64
Seasonal variation in cause-specific mortality: are there high-risk groups? 25-year follow-up of civil servants from the first Whitehall study. Int J Epidemiol (2001) 1.61
Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol (1985) (1999) 1.61
Waiting for coronary angiography: is there a clinically ordered queue? Lancet (2000) 1.58
Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2003) 1.57
Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.56
Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J (2009) 1.52
Evaluation of pulsed dose oxygen delivery during exercise in patients with severe chronic obstructive pulmonary disease. Thorax (1999) 1.49
Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation (1997) 1.48
Using nasal intermittent positive pressure ventilation on a general respiratory ward. J R Coll Physicians Lond (1998) 1.48
An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group. Respir Med (1999) 1.46
Hormone replacement therapy and cataract: a population-based case-control study. Eye (Lond) (2006) 1.44
Biological and behavioural explanations of social inequalities in coronary heart disease: the Whitehall II study. Diabetologia (2008) 1.43
General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart (2005) 1.41
Assessment and follow up of patients prescribed long term oxygen treatment. Thorax (1993) 1.41
Nicotine replacement therapy for a healthier nation. Nicotine replacement is cost effective and should be prescribable on the NHS. BMJ (1998) 1.41
MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res (2005) 1.37
Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2004) 1.37
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J (2004) 1.35
Coronary stent deployment in situs inversus. Heart (2001) 1.35
Acute infections and venous thromboembolism. J Intern Med (2011) 1.30
Differences in biological risk factors for cardiovascular disease between three ethnic groups in the Whitehall II study. Atherosclerosis (1999) 1.30
Effects of infant feeding practice on weight gain from birth to 3 years. Arch Dis Child (2008) 1.28
Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther (2005) 1.27
Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. Eur Respir J (1999) 1.27
The heterogeneity of chronic obstructive pulmonary disease. Thorax (2000) 1.25
Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med (2000) 1.24
Gender differences in descriptions of angina symptoms and health problems immediately prior to angiography: the ACRE study. Appropriateness of Coronary Revascularisation study. Soc Sci Med (2001) 1.24
A review of population-based studies on hypertension in Ghana. Ghana Med J (2012) 1.23
Erythrapheresis in patients with polycythaemia secondary to hypoxic lung disease. Br Med J (Clin Res Ed) (1983) 1.23
Organisational downsizing and musculoskeletal problems in employees: a prospective study. Occup Environ Med (2001) 1.22
Comparison of pressure and volume preset nasal ventilator systems in stable chronic respiratory failure. Eur Respir J (1993) 1.21
Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease. Thorax (2001) 1.21
Sarcoidosis presenting with stroke. Stroke (1989) 1.20
Is vitamin D deficiency important in the natural history of COPD? Thorax (2010) 1.18
Small intestinal perforation in Wegener's granulomatosis. Postgrad Med J (1982) 1.18
Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy. Eur Respir J (1997) 1.17
What is the harm-benefit ratio of Cox-2 inhibitors? Int J Epidemiol (2008) 1.16
Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2007) 1.13
Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J (1996) 1.11
Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control (2005) 1.10
Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J (2005) 1.10
Determinants of socioeconomic differences in change in physical and mental functioning. Soc Sci Med (1999) 1.10
Obstructive sleep apnea presenting as pseudopheochromocytoma: a case report. J Clin Endocrinol Metab (2004) 1.09
Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur Respir J (2010) 1.09